| Disclosure | Value |
|---|---|
| Disclosure | Value |
|---|---|
“The viability assessment period remained at five years to 31 December 2030 in the line with impairment review testing and the strategic planning process.”
Figures read from the report text and not reconciled against tagged iXBRL data. Treat them as indicative and check the source document.
Contractual cash flows, undiscounted — these include future interest and so exceed the carrying amounts above.
| Facility | Size | Drawn | Undrawn | Matures |
|---|---|---|---|---|
| Senior Notes | £68m | — | — | — |
| Bank and other borrowings | £144m | — | — | — |
| Cumulative Preference shares | £400k | — | — | — |
| Lease liabilities | £38m | — | — | — |
Extracted from filed annual reports. Disclosures are point-in-time and each section is labelled with the financial year it came from; always check the source document before acting on anything here.
“The viability assessment period remained at five years to 31 December 2030 in the line with impairment review testing and the strategic planning process.”
Figures read from the report text and not reconciled against tagged iXBRL data. Treat them as indicative and check the source document.
Contractual cash flows, undiscounted — these include future interest and so exceed the carrying amounts above.
| Facility | Size | Drawn | Undrawn | Matures |
|---|---|---|---|---|
| Senior Notes | £68m | — | — | — |
| Bank and other borrowings | £144m | — | — | — |
| Cumulative Preference shares | £400k | — | — | — |
| Lease liabilities | £38m | — | — | — |
Extracted from filed annual reports. Disclosures are point-in-time and each section is labelled with the financial year it came from; always check the source document before acting on anything here.
